SG11201903329WA - Method for preparing electrocompetent yeast cells, and method for using said cells - Google Patents
Method for preparing electrocompetent yeast cells, and method for using said cellsInfo
- Publication number
- SG11201903329WA SG11201903329WA SG11201903329WA SG11201903329WA SG11201903329WA SG 11201903329W A SG11201903329W A SG 11201903329WA SG 11201903329W A SG11201903329W A SG 11201903329WA SG 11201903329W A SG11201903329W A SG 11201903329WA SG 11201903329W A SG11201903329W A SG 11201903329WA
- Authority
- SG
- Singapore
- Prior art keywords
- international
- cells
- yeast
- pct
- boehmert
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N13/00—Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
- C12N1/16—Yeasts; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/7051—T-cell receptor (TcR)-CD3 complex
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1037—Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/90—Stable introduction of foreign DNA into chromosome
- C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
- C12N15/905—Stable introduction of foreign DNA into chromosome using homologous recombination in yeast
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Gastroenterology & Hepatology (AREA)
- Botany (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Crystallography & Structural Chemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102016121899.5A DE102016121899A1 (de) | 2016-11-15 | 2016-11-15 | Verfahren zur Herstellung von elektrokompetenten Hefezellen und Verfahren zur Verwendung dieser Zellen |
| PCT/EP2017/079011 WO2018091396A1 (fr) | 2016-11-15 | 2017-11-13 | Procédé de préparation de cellules de levure électrocompétentes et procédé d'utilisation desdites cellules |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201903329WA true SG11201903329WA (en) | 2019-05-30 |
Family
ID=60484335
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201903329WA SG11201903329WA (en) | 2016-11-15 | 2017-11-13 | Method for preparing electrocompetent yeast cells, and method for using said cells |
Country Status (23)
| Country | Link |
|---|---|
| US (3) | US10683495B2 (fr) |
| EP (1) | EP3541947B1 (fr) |
| JP (2) | JP7133226B2 (fr) |
| KR (1) | KR102194520B1 (fr) |
| CN (1) | CN109983130B (fr) |
| AR (1) | AR110087A1 (fr) |
| AU (1) | AU2017360666C1 (fr) |
| BR (1) | BR112019008385A2 (fr) |
| CA (1) | CA3043953A1 (fr) |
| DE (1) | DE102016121899A1 (fr) |
| DK (1) | DK3541947T3 (fr) |
| EA (1) | EA201990758A1 (fr) |
| ES (1) | ES2952039T3 (fr) |
| IL (1) | IL266538A (fr) |
| MA (1) | MA46835A (fr) |
| MX (1) | MX2019005622A (fr) |
| MY (1) | MY191776A (fr) |
| NZ (1) | NZ752651A (fr) |
| PH (1) | PH12019501001A1 (fr) |
| SG (1) | SG11201903329WA (fr) |
| TW (1) | TWI720268B (fr) |
| UA (1) | UA125076C2 (fr) |
| WO (1) | WO2018091396A1 (fr) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102017125888A1 (de) | 2017-11-06 | 2019-05-23 | Immatics Biotechnologies Gmbh | Neue konstruierte T-Zell-Rezeptoren und deren Verwendung in Immuntherapie |
| DK3707159T5 (da) | 2017-11-06 | 2024-08-26 | Immatics Biotechnologies Gmbh | Hidtil ukendte modificerede t-cellereceptorer og immunterapi med anvendelse deraf |
| US20200297768A1 (en) | 2019-03-19 | 2020-09-24 | Immatics US, Inc. | Cd28 t cell cultures, compositions, and methods of using thereof |
| DE102019108125B4 (de) | 2019-03-28 | 2022-02-03 | Immatics US, Inc. | Cd28 t-zellkulturen, zusammensetzungen und verfahren zu deren verwendung |
| DE102019121007A1 (de) | 2019-08-02 | 2021-02-04 | Immatics Biotechnologies Gmbh | Antigenbindende Proteine, die spezifisch an MAGE-A binden |
| JP2023525423A (ja) | 2020-01-15 | 2023-06-16 | イマティクス バイオテクノロジーズ ゲーエムベーハー | Ｐｒａｍｅに特異的に結合する抗原結合タンパク質 |
| AU2022270361A1 (en) | 2021-05-05 | 2023-11-16 | Immatics Biotechnologies Gmbh | Antigen binding proteins specifically binding prame |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2315612T3 (es) | 1991-04-10 | 2009-04-01 | The Scripps Research Institute | Genotecas de receptores heterodimericos usando fagemidos. |
| US8735330B2 (en) | 2007-08-20 | 2014-05-27 | Nextera As | pVII phage display |
| JP5647009B2 (ja) | 2008-03-03 | 2014-12-24 | アッヴィ・インコーポレイテッド | 酵母を形質転換するための方法 |
| JP5180326B2 (ja) | 2008-03-13 | 2013-04-10 | カーディアック ペースメイカーズ， インコーポレイテッド | 自律神経系の緊張度を調整する医療システム |
| JP2013535199A (ja) | 2010-07-28 | 2013-09-12 | イムノコア リミテッド | Ｔ細胞レセプター |
| EP3237908A1 (fr) * | 2014-12-22 | 2017-11-01 | Universität Zürich | Évolution dirigée de protéines membranaires dans des cellules eucaryotes à paroi cellulaire |
-
2016
- 2016-11-15 DE DE102016121899.5A patent/DE102016121899A1/de not_active Withdrawn
-
2017
- 2017-11-13 EA EA201990758A patent/EA201990758A1/ru unknown
- 2017-11-13 CA CA3043953A patent/CA3043953A1/fr active Pending
- 2017-11-13 NZ NZ752651A patent/NZ752651A/en not_active IP Right Cessation
- 2017-11-13 KR KR1020197013641A patent/KR102194520B1/ko active IP Right Grant
- 2017-11-13 BR BR112019008385A patent/BR112019008385A2/pt not_active Application Discontinuation
- 2017-11-13 CN CN201780069926.8A patent/CN109983130B/zh active Active
- 2017-11-13 MX MX2019005622A patent/MX2019005622A/es unknown
- 2017-11-13 AU AU2017360666A patent/AU2017360666C1/en active Active
- 2017-11-13 ES ES17805126T patent/ES2952039T3/es active Active
- 2017-11-13 DK DK17805126.4T patent/DK3541947T3/da active
- 2017-11-13 MA MA046835A patent/MA46835A/fr unknown
- 2017-11-13 EP EP17805126.4A patent/EP3541947B1/fr active Active
- 2017-11-13 WO PCT/EP2017/079011 patent/WO2018091396A1/fr unknown
- 2017-11-13 SG SG11201903329WA patent/SG11201903329WA/en unknown
- 2017-11-13 JP JP2019521754A patent/JP7133226B2/ja active Active
- 2017-11-13 UA UAA201904554A patent/UA125076C2/uk unknown
- 2017-11-13 MY MYPI2019002307A patent/MY191776A/en unknown
- 2017-11-15 AR ARP170103182A patent/AR110087A1/es unknown
- 2017-11-15 US US15/813,879 patent/US10683495B2/en active Active
- 2017-11-15 TW TW106139472A patent/TWI720268B/zh active
-
2019
- 2019-05-07 PH PH12019501001A patent/PH12019501001A1/en unknown
- 2019-05-08 IL IL266538A patent/IL266538A/en unknown
-
2020
- 2020-05-08 US US16/869,784 patent/US11104894B2/en active Active
-
2021
- 2021-07-29 US US17/389,061 patent/US20210355478A1/en active Pending
-
2022
- 2022-06-17 JP JP2022097799A patent/JP2022130501A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201903329WA (en) | Method for preparing electrocompetent yeast cells, and method for using said cells | |
| SG11201811048UA (en) | Single-cell transcript sequencing | |
| SG11201807252QA (en) | Anti-lag-3 antibodies | |
| SG11201810003UA (en) | Using programmable dna binding proteins to enhance targeted genome modification | |
| SG11201811431VA (en) | Multispecific antibodies against cd40 and cd137 | |
| SG11201810605UA (en) | Selectively altering microbiota for immune modulation | |
| SG11201805950UA (en) | Self-assembled nanostructures and separation membranes comprising aquaporin water channels and methods of making and using them | |
| SG11201808622SA (en) | Chimeric receptors to flt3 and methods of use thereof | |
| SG11201809344QA (en) | Process for synthesizing 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)-pyridin-3-yl)methoxy)benzaldehyde | |
| SG11201807187XA (en) | Binding members to pd-l1 | |
| SG11201907857RA (en) | Edible and biodegradable utensils | |
| SG11201900772YA (en) | Gene editing of car-t cells for the treatment of t cell malignancies with chimeric antigen receptors | |
| SG11201811336TA (en) | Method for producing an electrode catalyst from a perovskite metal oxide | |
| SG11201906748PA (en) | Microbial cells, methods of producing the same, and uses thereof | |
| SG11201407774XA (en) | Conversion of biomass | |
| SG11201804997XA (en) | Process for preparing non-cariogenic, sustained energy release juice | |
| SG11201810965YA (en) | 1h-pyrazolo[4,3-b]pyridines as pde1 inhibitors | |
| SG11201408251SA (en) | A pharmaceutical composition containing nicotinic acid and/or nicotinamide and/or tryptophan for positively influencing the intestinal microbiota | |
| SG11201809530PA (en) | Method for recovery of phosphate | |
| SG11201904535VA (en) | Prevention and treatment of bone and cartilage damage or disease | |
| SG11201909419XA (en) | Hydrogel for cell culture and biomedical applications | |
| SG11201808762XA (en) | Diagnostic methods for patient specific therapeutic decision making in cancer care | |
| SG11201809594WA (en) | Nicotine particles and compositions | |
| SG11201805001UA (en) | Method of treating influenza a | |
| SG11201407800SA (en) | Selective binding of biological targets to solid phase ureides |